The bone marrow in Hodgkin's disease: the non-involved marrow. 1978

J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld

One hundred and nineteen methacrylate-embedded trephine biopsy specimens from 80 patients with Hodgkin's disease are reviewed. Although marrow involvement was found in 4% of the untreated patients, the present study was mainly concerned with the marrow unaffected by specific infiltrates and in negative specimens. The non-involved bone marrow in Hodgkin's disease invariably showed alterations of three types; stromal damage, inflammatory infiltration, and disturbed haematopoiesis. Each of these features can be found in the absence of one or both of the others. In severe examples, all three of these components usually occur simultaneously, giving histological pictures that mimic Hodgkin-specific infiltrates, sometimes in association with clinical suggestions of bone marrow involvement or replacement. But trephine biopsies of sufficiently high histological quality offer alternative explanations for the pancytopenia, for instance intramedullary phagocytosis, reactive sclerosing inflammation resembling auto-immune disorders, or a disturbance of haematopoiesis itself. This disturbance could be due to a defect inherent in the haematopoiesis associated with Hodgkin's disease, possibly predisposing for leukaemia in longterm survivors who have received chemotherapy and/or irradiation. The disturbed erythropoiesis proved to be strongly correlated with the stage of the disease at the time of biopsy. This finding could contribute to staging procedures, when laparotomy is contraindicated.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008689 Methacrylates Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group. Methacrylate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010198 Pancytopenia Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. Pancytopenias
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006652 Histological Techniques Methods of preparing tissue for examination and study of the origin, structure, function, or pathology. Histologic Technic,Histologic Technics,Histologic Technique,Histologic Techniques,Histological Technics,Technic, Histologic,Technics, Histologic,Technique, Histologic,Techniques, Histologic,Histological Technic,Histological Technique,Technic, Histological,Technics, Histological,Technique, Histological,Techniques, Histological
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
August 1994, Seminars in oncology,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
December 1975, Cancer,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
January 1990, Cancer treatment and research,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
November 1971, Cancer research,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
March 1975, The British journal of cancer. Supplement,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
April 1983, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
December 1988, Indian journal of cancer,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
February 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
April 1991, Journal of clinical pathology,
J Te Velde, and G J Den Ottolander, and P J Spaander, and C Van Den Berg, and C A Hartgrink-Groeneveld
January 1992, Bone marrow transplantation,
Copied contents to your clipboard!